9-(tert-butylglycylamido)minocycline,
GAR 936,
GAR-936,
GAR936,
TBG-MINO,
tigecycline,
Tygacil,
Tigecycline,
220620-09-7,
Tygacil,
WAY-GAR-936,
GAR-936,
TBG-MINO,
GAR 936,
GAR-936,Tigecycline,
Tigecycline hydrate,
UNII-70JE2N95KR,
70JE2N95KR,
(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide,
CHEBI:149836,
Tigecyclin,
(4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,
(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
Q-101396,
Tigilcycline,
C29H39N5O8,
Tygacil(TM),
Tygacil (TN),
Tigecycline [USAN],
9-t-Butylglycylamido-minocycline hydrate,
Tigecycline (JAN/USAN),
Tigeciclina,
Tigecyclinum,
9-t-Butylglycylamido minocycline,
Haizheng Li Xing,
Tigecycline 95%,
NCGC00183095-01,
(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
(4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-,
2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-[[[(1,1-DIMETHYLETHYL)AMINO]ACETYL]AMINO]-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-,
AC1NQZEU,
PubChem21336,
DSSTox_CID_28507,
DSSTox_RID_82779,
DSSTox_GSID_48581,
MLS006010079,
SCHEMBL101795,
SCHEMBL105082,
SCHEMBL237962,
Tigecycline [USAN:INN:BAN],
AC1O714W,
CHEMBL376140,
DTXSID2048581,
HSDB 8172,
SYN3024,
9-tert-Butylglycylamidominocycline,
FPZLLRFZJZRHSY-HJYUBDRYSA-N,
SOVUOXKZCCAWOJ-HJYUBDRYSA-N,
BCPP000045,
HMS3714I13,
ACT08710,
BCP01397,
HY-B0117,
Tox21_112910,
CT0198,
MFCD00935753,
s1403,
ZINC14879972,
AKOS015895663,
AKOS025401452,
ZINC100022633,
ZINC102200515,
AC-1798,
AN-6306,
CS-1876,
DB00560,
RL02680,
220620-09-7 (anhy.),
(4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide,
121GE002,
AS-30703,
BC677670,
BR-73038,
N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide,
SC-20200,
SMR002530064,
AB0011463,
AB2000089,
LS-186580,
LS-187002,
LS-187782,
ST2413997,
A5226,
AM20090708,
CAS-220620-09-7,
FT-0657279,
Tygacil;GAR-936;WAY-GAR-936;TBG-MINO,
C12012,
D01079,
S-5066,
AB01566818_01,
620T097,
Tigecycline, Antibiotic for Culture Media Use Only,
I06-1089,
(4S,4AS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxa,
(4s,4as,5ar,12as)-9-(2-t-butylaminoacetylamino)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydronaphthacene-2-carboxamide,
(4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-,
N-((5aR,6aS,7S,10aS,Z)-9-(amino(hydroxy)methylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl)-2-(tert-butylamino)acetamide,
N-[(5aR,6aS,7S,9E,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide,
N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide,
Glycylcycline,
D0G4OD,
cc-152,
GAR936,
HSDB 5738,
9-(tert-butylglycylamido)minocycline,
RW2764,
ACN-040789,
CID5282044,
CS-O-02445,
Tigecycline, 99% - 100MG 100mg,
CL 331002,
CL-331002,
T3589,
C119092,
D000078304,
Tygacil, GAR-936, WAY-GAR-936, TBG-MINO, Tigecycline,
Tigecycline, Tigilcycline, WAY-GAR-936, GAR-936, TBG-MINO, Tygacil,
1229002-07-6,
2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-,
T1C,